Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2011 August;102(4) > Minerva Medica 2011 August;102(4):333-8

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

REVIEWS  PROSTATE CANCER UPDATE


Minerva Medica 2011 August;102(4):333-8

language: English

Robot assisted laparoscopic prostatectomy. Striving for Trifecta outcomes in localised prostate cancer

Barnett C. 1, Kumar P. 1, Challacombe B. 1, Dasgupta P. 1,2

1 The Urology Centre, Guy’s Hospital, London, UK;
2 MRC Centre for Transplantation, NIHR Biomedical Research Centre, King’s College London, King’s Health Partners, Guy’s Hospital, London, UK


PDF  


Radical prostatectomy (RP) is the gold standard treatment for localised prostate cancer and its oncological effectiveness has been demonstrated so far. With no doubt though, RP has significant potential morbidity and the selection of patients who will likely benefit from surgery while minimising the side effects of incontinence and erectile dysfunction is fundamental. Robot-assisted radical prostatectomy allows us to achieve oncological control, early continence and preservation of erectile function all in one. Thus, analysing its role is of utmost importance.

top of page

Publication History

Cite this article as

Corresponding author e-mail

prokarurol@gmail.com